tiprankstipranks
Biogen Inc. (BIIB)
:BIIB
US Market

Biogen (BIIB) Income Statement

Compare
4,739 Followers

Biogen Income Statement

Last quarter (Q4 2024), Biogen's total revenue was $2.45B, an increase of 2.87% from the same quarter last year. In Q4, Biogen's net income was $266.80M. See Biogen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.68B$ 9.84B$ 10.17B$ 10.98B$ 13.44B
Gross Profit
$ 9.68B$ 7.30B$ 7.90B$ 8.87B$ 11.64B
Operating Expenses
$ 4.45B$ 6.01B$ 4.99B$ 6.06B$ 7.19B
Depreciation and Amortization
$ 0.00$ 494.80M$ 518.70M$ 487.30M$ 457.00M
EBITDA
$ 0.00$ 2.38B$ 4.36B$ 2.49B$ 5.73B
Operating Income
$ 5.23B$ 2.10B$ 2.32B$ 2.84B$ 4.55B
Other Income/Expenses
$ -3.32B$ -800.50M$ 331.40M$ -1.10B$ 497.40M
Pretax Income
$ 1.91B$ 1.30B$ 3.59B$ 1.75B$ 5.05B
Net Income
$ 1.63B$ 1.16B$ 3.05B$ 1.56B$ 4.00B
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 11.20$ 8.02$ 20.97$ 10.44$ 24.86
Diluted EPS
$ 11.19$ 7.97$ 20.87$ 10.40$ 24.80
Weighted Average Shares Outstanding
145.70M 144.70M 145.30M 149.10M 160.90M
Weighted Average Shares Outstanding (Diluted)
145.90M 145.60M 146.00M 149.60M 161.30M
Currency in USD

Biogen Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis